Aethlon Medical Inc. Common Stock
(NASDAQ:AEMD)
Description
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company is developing Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh for studies related to head and neck cancer. The company is based in San Diego, California.
AEMD Overview
None
Sector |
Health Care |
Industry |
Medical/Dental Instruments |
Previous Close |
$0.3800 |
Previous Close Volume |
198310 |
Latest News
- Aethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for Transplant 24 Jul 2023 08:30:03